LIFEARC has a total of 57 patent applications. It decreased the IP activity by 71.0%. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ABBVIE INC, TSZYANSU KHENZHUJ MEDSIN KO LTD and ZENTARIS AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | United States | 10 | |
#3 | Australia | 6 | |
#4 | Canada | 6 | |
#5 | China | 5 | |
#6 | WIPO (World Intellectual Property Organization) | 5 | |
#7 | United Kingdom | 4 | |
#8 | Hong Kong | 2 | |
#9 | Republic of Korea | 2 | |
#10 | Serbia | 2 | |
#11 | Brazil | 1 | |
#12 | Hungary | 1 | |
#13 | Israel | 1 | |
#14 | Montenegro | 1 | |
#15 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Mciver Edward Giles | 14 |
#2 | Large Jonathan | 12 |
#3 | Osborne Simon | 12 |
#4 | Osborne Joanne | 12 |
#5 | Winter-Holt Jon James | 12 |
#6 | Lewis Stephen | 12 |
#7 | Matthews David | 9 |
#8 | Patel Seema | 8 |
#9 | Watson Phil | 8 |
#10 | Brown Alex | 8 |
Publication | Filing date | Title |
---|---|---|
GB202016449D0 | Cyclic peptides | |
GB202003462D0 | Cyclic peptides | |
GB201820006D0 | Humanised anti-IL17BR antibody | |
GB201817943D0 | Galanin-2 receptor agonists | |
EP3560555A1 | A composition for treating one or more estrogen related diseases | |
AU2017388131A1 | Oxazole derivatives for use in the treatment of cancer | |
EP3562825A1 | Oxazole derivatives for use in the treatment of cancer | |
AU2017283407A1 | Substituted tricyclic heterocyclic compounds and use thereof |